In the multicentre clinical and pharmacogenetic GENDEP study ( Genome-based Therapeutic Drugs for Depression ) , the effect of the serotonin transporter gene promoter polymorphism 5-HTTLPR on sexual function was investigated during treatment with escitalopram ( SSRI ) and nortriptyline ( tricyclic antidepressant ) .